Talukdar Lavina 4
4 · Monopar Therapeutics · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Talukdar Lavina
Director
Transactions
- Award
Stock Options
2025-03-04+5,683→ 5,683 totalExercise: $31.70Exp: 2035-03-04→ Common Stock (5,683 underlying)
Footnotes (1)
- [F1]Options vest 25% quarterly on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025